Presentation Fellows 2024 Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come Presenter: David J. Cohen April 12, 2024
Presentation ACC 2024 Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC) Presenter: Rasha K. Al-Lamee April 08, 2024
Presentation ACC 2024 Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock Presenter: Jacob Eifer Møller April 07, 2024
Presentation ACC 2024 Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial Presenter: Gregg W Stone April 07, 2024
Presentation ACC 2024 The Effect of Edetate Disodium-based Chelation on Cardiovascular Events in Patients with a Prior Myocardial Infarction and Diabetes – Results of the TACT2 Randomized Trial Presenter: Gervasio A. Lamas April 07, 2024
Presentation ACC 2024 Empagliflozin after Acute Myocardial Infarction: The EMPACT-MI trial Presenter: Javed Butler April 06, 2024
Presentation THT 2024 Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock Presenter: James W. Schurr March 06, 2024
Presentation THT 2024 A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms. Presenter: Thomas Hanff March 06, 2024
Presentation THT 2024 DPP3-Based Biotherapy in Cardiogenic Shock Presenter: Mahir Karakas March 06, 2024
Presentation THT 2024 The Conundrum of Clinical Trials in Cardiogenic Shock Presenter: JoAnn Lindenfeld March 06, 2024
Presentation THT 2024 Pulmonary Artery Catheter in Shock (PACCS) Presenter: Shashank Shekhar Sinha March 05, 2024
Presentation THT Abstracts 2024 Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry Presenter: Jacob Abraham March 05, 2024
Presentation THT Abstracts 2024 Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group Presenter: Kevin John March 05, 2024
Presentation THT Abstracts 2024 Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group Presenter: Justin Fried March 05, 2024
Presentation THT Abstracts 2024 Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function Presenter: Eduardo Arias March 05, 2024
Presentation THT Abstracts 2024 Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support Presenter: Kevin John March 05, 2024
Presentation THT Abstracts 2024 Sex Differences in Acute Heart Failure Related Cardiogenic Shock Presenter: Rebecca Smoller March 05, 2024
Presentation THT Abstracts 2024 Newly Developed Cardiogenic Shock Team: 10 month update Presenter: Robin Miller March 05, 2024
Presentation THT Abstracts 2024 Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone Presenter: Daniel Snyder March 05, 2024